Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3280625rdf:typepubmed:Citationlld:pubmed
pubmed-article:3280625lifeskim:mentionsumls-concept:C0001617lld:lifeskim
pubmed-article:3280625lifeskim:mentionsumls-concept:C0032768lld:lifeskim
pubmed-article:3280625lifeskim:mentionsumls-concept:C1552617lld:lifeskim
pubmed-article:3280625lifeskim:mentionsumls-concept:C0282443lld:lifeskim
pubmed-article:3280625lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:3280625pubmed:issue3lld:pubmed
pubmed-article:3280625pubmed:dateCreated1988-5-10lld:pubmed
pubmed-article:3280625pubmed:abstractTextA short course of corticosteroids is frequently used in herpes zoster to prevent postherpetic neuralgia. To clarify the evidence behind this routine practice, we reviewed the three randomized controlled trials on this subject. Although in all three similar dosages of corticosteroids (40 mg to 60 mg prednisone daily for 2 to 4 weeks) were used, deficiencies in reported clinical characteristics of study subjects, the potential for bias in the ascertainment of pain duration, and the inability to exclude type II error make it impossible to determine whether or not this practice is effective. More research on this subject is needed, with greater attention to good study methodology.lld:pubmed
pubmed-article:3280625pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3280625pubmed:languageenglld:pubmed
pubmed-article:3280625pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3280625pubmed:citationSubsetIMlld:pubmed
pubmed-article:3280625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3280625pubmed:statusMEDLINElld:pubmed
pubmed-article:3280625pubmed:monthMarlld:pubmed
pubmed-article:3280625pubmed:issn0190-9622lld:pubmed
pubmed-article:3280625pubmed:authorpubmed-author:PhilbrickJ...lld:pubmed
pubmed-article:3280625pubmed:authorpubmed-author:PostB TBTlld:pubmed
pubmed-article:3280625pubmed:issnTypePrintlld:pubmed
pubmed-article:3280625pubmed:volume18lld:pubmed
pubmed-article:3280625pubmed:ownerNLMlld:pubmed
pubmed-article:3280625pubmed:authorsCompleteYlld:pubmed
pubmed-article:3280625pubmed:pagination605-10lld:pubmed
pubmed-article:3280625pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3280625pubmed:meshHeadingpubmed-meshheading:3280625-...lld:pubmed
pubmed-article:3280625pubmed:meshHeadingpubmed-meshheading:3280625-...lld:pubmed
pubmed-article:3280625pubmed:meshHeadingpubmed-meshheading:3280625-...lld:pubmed
pubmed-article:3280625pubmed:meshHeadingpubmed-meshheading:3280625-...lld:pubmed
pubmed-article:3280625pubmed:meshHeadingpubmed-meshheading:3280625-...lld:pubmed
pubmed-article:3280625pubmed:meshHeadingpubmed-meshheading:3280625-...lld:pubmed
pubmed-article:3280625pubmed:year1988lld:pubmed
pubmed-article:3280625pubmed:articleTitleDo corticosteroids prevent postherpetic neuralgia? A review of the evidence.lld:pubmed
pubmed-article:3280625pubmed:affiliationDepartment of Medicine, University of Virginia, School of Medicine, Charlottesville 22908.lld:pubmed
pubmed-article:3280625pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3280625pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:3280625pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3280625lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3280625lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3280625lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3280625lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3280625lld:pubmed